Source:http://linkedlifedata.com/resource/pubmed/id/18701271
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
12
|
pubmed:dateCreated |
2008-11-17
|
pubmed:abstractText |
The aim of the current study was to investigate the effect of 14-membered ring macrolide clarithromycin (CAM) on migration induced by human plasma fibronectin (HFn) or on contraction of human fetal lung fibroblasts (HFL-1). METHODS AND RESULTS: Using the blindwell chamber technique, CAM (10(-5) M) inhibited the migration of HFL-1 60.2+/-4.0% (p<0.05). Other antibiotics, such as ampicillin, minocycline or azithromycin had no effects on HFL-1 migration. The effect of CAM was concentration dependent. HFL-1 migration, stimulated by TXA(2) analog was also inhibited by CAM. Clarithromycin had no effect on HFL-1 mediated gel contraction that was another function of fibroblast at the wound area. CONCLUSIONS: Clarithromycin may contribute to the regulation of the wound healing response following injury by inhibiting fibroblast migration. These results could represent the therapeutic benefits of CAM.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Bacterial Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Clarithromycin,
http://linkedlifedata.com/resource/pubmed/chemical/Collagen,
http://linkedlifedata.com/resource/pubmed/chemical/Fibronectins,
http://linkedlifedata.com/resource/pubmed/chemical/Gels
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1532-3064
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
102
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1769-76
|
pubmed:meshHeading |
pubmed-meshheading:18701271-Anti-Bacterial Agents,
pubmed-meshheading:18701271-Cell Survival,
pubmed-meshheading:18701271-Cells, Cultured,
pubmed-meshheading:18701271-Chemotaxis,
pubmed-meshheading:18701271-Clarithromycin,
pubmed-meshheading:18701271-Collagen,
pubmed-meshheading:18701271-Dose-Response Relationship, Drug,
pubmed-meshheading:18701271-Fibroblasts,
pubmed-meshheading:18701271-Fibronectins,
pubmed-meshheading:18701271-Gels,
pubmed-meshheading:18701271-Humans,
pubmed-meshheading:18701271-Lung
|
pubmed:year |
2008
|
pubmed:articleTitle |
Clarithromycin inhibits fibroblast migration.
|
pubmed:affiliation |
Department of Respiratory Medicine, The University of Tokyo, Graduate School of Medicine, 7-3-1 Hongo Bunkyo-ku, Tokyo 113-8655, Japan. koyama-tky@umin.ac.jp
|
pubmed:publicationType |
Journal Article
|